Skip to main content
BDTX logo

BDTX

Black Diamond Therapeutics, Inc.

$1.32

4.74%

Trade Ideas Performance

Latest Closed Trade Idea

$1.32

4.74%
Loading...
We are loading your data. Please wait a moment.

Sentiment

News

3

Social

11

About

Events of Black Diamond Therapeutics, Inc. (BDTX)

Over the past six months, Black Diamond Therapeutics' stock (BDTX) has trended down by 29.63%, experiencing its largest daily decrease of 35.8% on May 22, 2026. The stock increased by 7.26% on August 5, 2026, following the company's Q2 2026 financial results and corporate update. On September 2, 2026, it decreased by 1.87% after announcing participation in the H.C. Wainwright 28th Annual Global Investment Conference. A director took stock in lieu of cash fees on September 21, 2026. In early November 2026, the stock was downgraded from "Strong Buy" to "Buy" due to a slower-than-expected start of Phase 3 trials for silevertinib, despite strong Phase 2 results, particularly in brain metastases. Key upcoming catalysts include updated Phase 2 data and FDA feedback expected in late 2026.

FAQ

Related Assets

Price action provided by Massive. Fundamentals, news and corporate events provided by FactSet. NLP support provided by Perplexity & Gemini. All data is provided for informational purposes only.

Make every trade make sense.

Sign up free. No card required. Three trade ideas a day, the AI analyst, the community - on us.

Get started for FREE (opens in new tab)
Edge Hound mobile app preview on iPhone

Join us and trade with people
who think like you.

The Edge Hound Discord is where serious self-directed investors talk strategy, share setups, and learn from each other. Free to join with any plan - including Free.

Free to join with any plan - including Free.

Join our Discord community (opens in new tab)